Biodexa Pharmaceuticals Reports Interim 2026 Results, Progress in eRapa and MTX240 Programs, and $3.5 Million Post-Period FundraiseSeptember 11, 2026
Frazier adds $1.1B+ to small and mid-sized biotech fundBy AdminBitSeptember 11, 20260 Frazier Life Sciences has brought in more than $1.1 billion in capital commitments for its public fund reserved for small- and mid-cap drugmakers.
Frazier & Deeter picks new assurance partner in North CarolinaBy AdminBitSeptember 7, 20260 US-based professional services company Frazier & Deeter (FD) has appointed Jeremy Jacobs as a partner as it seeks to strengthen its presence in Charlotte, North Carolina.
